Anthony N Coles
CIK 1197018 · View on SEC EDGAR ↗
Insider
First SEC filing: July 22, 2005 · Latest: July 22, 2005
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 31 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
31 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 15, 2021 | REGN | S 10b5-1 | 300 | $651.36 | $195,408 | 12,550 Direct | -2.33% | Disposed | 28.2% (price as of 2026-08-20) |
| Sept. 15, 2021 | REGN | S 10b5-1 | 1,101 | $652.95 | $718,898 | 11,449 Direct | -8.77% | Disposed | 27.9% (price as of 2026-08-20) |
| Sept. 15, 2021 | REGN | S 10b5-1 | 800 | $653.31 | $522,648 | 10,649 Direct | -6.99% | Disposed | 27.8% (price as of 2026-08-20) |
| Sept. 15, 2021 | REGN | S 10b5-1 | 403 | $655.14 | $264,021 | 10,246 Direct | -3.78% | Disposed | 27.5% (price as of 2026-08-20) |
| Sept. 15, 2021 | REGN | S 10b5-1 | 1,400 | $656.48 | $919,072 | 8,846 Direct | -13.66% | Disposed | 27.2% (price as of 2026-08-20) |
| Sept. 15, 2021 | REGN | S 10b5-1 | 835 | $657.53 | $549,038 | 8,011 Direct | -9.44% | Disposed | 27.0% (price as of 2026-08-20) |
| Sept. 15, 2021 | REGN | S 10b5-1 | 935 | $658.65 | $615,838 | 7,076 Direct | -11.67% | Disposed | 26.8% (price as of 2026-08-20) |
| Sept. 15, 2021 | REGN | S 10b5-1 | 300 | $659.00 | $197,700 | 6,776 Direct | -4.24% | Disposed | 26.7% (price as of 2026-08-20) |
| Sept. 15, 2021 | REGN | S 10b5-1 | 448 | $660.78 | $296,029 | 6,328 Direct | -6.61% | Disposed | 26.4% (price as of 2026-08-20) |
| Sept. 15, 2021 | REGN | S 10b5-1 | 3,344 | $661.56 | $2,212,257 | 2,984 Direct | -52.84% | Disposed | 26.2% (price as of 2026-08-20) |
| Sept. 15, 2021 | REGN | S 10b5-1 | 3 | $662.55 | $1,988 | 2,981 Direct | -0.10% | Disposed | 26.0% (price as of 2026-08-20) |
| Sept. 15, 2021 | REGN | S 10b5-1 | 905 | $663.73 | $600,676 | 2,076 Direct | -30.36% | Disposed | 25.8% (price as of 2026-08-20) |
| Sept. 15, 2021 | REGN | S 10b5-1 | 1,174 | $664.32 | $779,912 | 902 Direct | -56.55% | Disposed | 25.7% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | REGN | Non-Qualified Stock Option (right to buy) | Common Stock (1,962) | $772.76 | Jan. 2, 2036 | 1,962 | Acquired |
| Sept. 15, 2021 | REGN | Non-Qualified Stock Option (right to buy) | Common Stock (5,039) | $345.47 | Jan. 27, 2027 | 5,039 | Disposed |
| Sept. 15, 2021 | REGN | Non-Qualified Stock Option (right to buy) | Common Stock (6,909) | $380.95 | Jan. 2, 2028 | 6,909 | Disposed |
| Nov. 13, 2020 | REGN | Non-Qualified Stock Option (right to buy) | Common Stock (11) | $345.47 | Jan. 27, 2027 | 11 | Disposed |
| Jan. 2, 2019 | REGN | Non-Qualified Stock Option (right to buy) | Common Stock (3,784) | $371.40 | Jan. 2, 2029 | 3,784 | Acquired |
| Jan. 2, 2018 | REGN | Non-Qualified Stock Option (right to buy) | Common Stock (6,909) | $380.95 | Jan. 2, 2028 | 6,909 | Acquired |
| May 31, 2017 | CRSP | Stock Option (Right to Buy) | Common Shares (15,000) | $13.62 | May 31, 2027 | 15,000 | Acquired |
| Jan. 27, 2017 | REGN | Non-Qualified Stock Option (right to buy) | Common Stock (13,050) | $345.47 | Jan. 27, 2027 | 13,050 | Acquired |
| Oct. 18, 2016 | CRSP | Stock Option (Right to Buy) | Common Shares (15,000) | $14.00 | Oct. 18, 2026 | 15,000 | Acquired |
| May 11, 2011 | LH | Non-qualified Stock Options [F1] | Common Stock (2,600) | $98.49 | May 11, 2021 | 2,600 | Acquired |
| Jan. 3, 2011 | LH | Non-qualified Stock Options [F1] | Common Stock (1,000) | $89.57 | Jan. 3, 2021 | 1,000 | Acquired |
| July 20, 2005 | VRTX | Stock Option | Common Stock (18,000) | $17.16 | July 19, 2015 | 18,000 | Acquired |
| Feb. 3, 2005 | VRTX | Stock Option | Common Stock (24,750) | $10.41 | Feb. 2, 2015 | 24,750 | Acquired |
| Oct. 7, 2004 | VRTX | Stock Option | Common Stock (18,000) | $11.27 | Oct. 6, 2014 | 18,000 | Acquired |
| March 17, 2004 | VRTX | Stock Option | Common Stock (14,400) | $9.69 | March 16, 2014 | 14,400 | Acquired |
| Dec. 11, 2003 | VRTX | Stock Option | Common Stock (14,400) | $9.07 | Dec. 11, 2013 | 14,400 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
VRTX
President, Commercial Operations Pharmaceutical Products| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2003 | — | — | $17,683 | — | — | — | — | — |
| 2002 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.